TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.


Options:
A: Arm Label: lamotrigine 300; Type: EXPERIMENTAL; Interventions: Drug: lamotrigine, 300 mg/day | Arm Label: lamotrigine 250; Type: EXPERIMENTAL; Interventions: Drug: lamotrigine, 250 mg/day | Intervention Type: DRUG; Name: lamotrigine, 300 mg/day; Assigned to Arm(s): lamotrigine 300 | Intervention Type: DRUG; Name: lamotrigine, 250 mg/day; Assigned to Arm(s): lamotrigine 250
B: Arm Label: Keppra XR 1000 mg/day; Type: EXPERIMENTAL; Interventions: Drug: Keppra XR | Arm Label: Keppra XR 2000 mg/day; Type: EXPERIMENTAL; Interventions: Drug: Keppra XR | Intervention Type: DRUG; Name: Keppra XR; Assigned to Arm(s): Keppra XR 1000 mg/day | Intervention Type: DRUG; Name: Keppra XR; Assigned to Arm(s): Keppra XR 2000 mg/day
C: Arm Label: Levetiracetam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Levetiracetam | Arm Label: Carbamazepine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbamazepine | Arm Label: Lamotrigine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lamotrigine | Intervention Type: DRUG; Name: Levetiracetam; Assigned to Arm(s): Levetiracetam | Intervention Type: DRUG; Name: Carbamazepine; Assigned to Arm(s): Carbamazepine | Intervention Type: DRUG; Name: Lamotrigine; Assigned to Arm(s): Lamotrigine
D: Intervention Type: DRUG; Name: phenobarbitone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: carbamazepine; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.


Options:
A: Arm Label: Levetiracetam; Type: EXPERIMENTAL; Interventions: Drug: Levetiracetam | Arm Label: Carabamazepine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carabamazepine | Intervention Type: DRUG; Name: Levetiracetam; Assigned to Arm(s): Levetiracetam | Intervention Type: DRUG; Name: Carabamazepine; Assigned to Arm(s): Carabamazepine
B: Arm Label: Zonisamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Zonisamide | Arm Label: Carbamazepine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbamazepine | Intervention Type: DRUG; Name: Zonisamide; Assigned to Arm(s): Zonisamide | Intervention Type: DRUG; Name: Carbamazepine; Assigned to Arm(s): Carbamazepine
C: Intervention Type: DRUG; Name: phenobarbitone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: carbamazepine; Assigned to Arm(s): N/A
D: Arm Label: Levetiracetam; Type: EXPERIMENTAL; Interventions: Drug: Levetiracetam | Arm Label: Older Antepileptic Drugs; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbamazepine Controlled Release (CBZ-CR), Drug: Valproate Extended Release | Intervention Type: DRUG; Name: Levetiracetam; Assigned to Arm(s): Levetiracetam | Intervention Type: DRUG; Name: Carbamazepine Controlled Release (CBZ-CR); Assigned to Arm(s): Older Antepileptic Drugs | Intervention Type: DRUG; Name: Valproate Extended Release; Assigned to Arm(s): Older Antepileptic Drugs

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bracing in Patellofemoral Osteoarthritis: A Clinical Trial
Brief Summary: Osteoarthritis, sometimes called degenerative joint disease, is the most common form of arthritis. It occurs when the cartilage in joints wears down over time. Symptoms can include pain, tenderness, stiffness, and inflammation. Studies have suggested that symptoms of knee osteoarthritis may be caused by abnormalities at the patellofemoral joint, which is the joint between the kneecap, called the patella, and the thigh bone, called the femur. This study will determine whether wearing a knee brace that realigns the patella over the femur is effective in relieving pain and improving function in adults with knee osteoarthritis.


Options:
A: Arm Label: Intervention to placebo; Type: OTHER; Interventions: Device: Patellofemoral realigning knee brace, Device: Non-aligning knee brace | Arm Label: Placebo to intervetion; Type: OTHER; Interventions: Device: Patellofemoral realigning knee brace, Device: Non-aligning knee brace | Intervention Type: DEVICE; Name: Patellofemoral realigning knee brace; Assigned to Arm(s): Intervention to placebo, Placebo to intervetion | Intervention Type: DEVICE; Name: Non-aligning knee brace; Assigned to Arm(s): Intervention to placebo, Placebo to intervetion
B: Arm Label: Kinesio taping group; Type: EXPERIMENTAL; Interventions: Other: Taping application | Arm Label: Non specific taping; Type: SHAM_COMPARATOR; Interventions: Other: Taping application | Intervention Type: OTHER; Name: Taping application; Assigned to Arm(s): Kinesio taping group, Non specific taping
C: Arm Label: Real mobilization-with-movement (MWM); Type: EXPERIMENTAL; Interventions: Other: Real mobilization-with-movement (MWM) | Arm Label: Sham mobilization-with-movement (MWM); Type: SHAM_COMPARATOR; Interventions: Other: Sham mobilization-with-movement (MWM) | Intervention Type: OTHER; Name: Real mobilization-with-movement (MWM); Assigned to Arm(s): Real mobilization-with-movement (MWM) | Intervention Type: OTHER; Name: Sham mobilization-with-movement (MWM); Assigned to Arm(s): Sham mobilization-with-movement (MWM)
D: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Other: application of kinesio taping | Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Other: application of kinesio taping | Intervention Type: OTHER; Name: application of kinesio taping; Assigned to Arm(s): Placebo group, intervention group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Phase II Study of ECF-C, IC-C, or FOLFOX-C in Metastatic Esophageal and GE Junction Cancer
Brief Summary: RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Giving more than one chemotherapy drug (combination chemotherapy) together with cetuximab may kill more tumor cells.

PURPOSE: This randomized phase II trial is studying three different combination chemotherapy regimens to compare how well they work when given together with cetuximab in treating patients with metastatic esophageal cancer or gastroesophageal junction cancer.


Options:
A: Arm Label: AZD4547; Type: EXPERIMENTAL; Interventions: Drug: AZD4547 | Arm Label: Paclitaxel; Type: ACTIVE_COMPARATOR; Interventions: Drug: paclitaxel | Intervention Type: DRUG; Name: AZD4547; Assigned to Arm(s): AZD4547 | Intervention Type: DRUG; Name: paclitaxel; Assigned to Arm(s): Paclitaxel
B: Arm Label: Physician choice chemotherapy+Best Supportive Care (BSC); Type: EXPERIMENTAL; Interventions: Drug: Irinotecan, Drug: Paclitaxel, Other: Best Supportive Care (BSC) | Arm Label: Avelumab+BSC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Avelumab, Other: Best Supportive Care (BSC) | Intervention Type: DRUG; Name: Avelumab; Assigned to Arm(s): Avelumab+BSC | Intervention Type: DRUG; Name: Irinotecan; Assigned to Arm(s): Physician choice chemotherapy+Best Supportive Care (BSC) | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Physician choice chemotherapy+Best Supportive Care (BSC) | Intervention Type: OTHER; Name: Best Supportive Care (BSC); Assigned to Arm(s): Avelumab+BSC, Physician choice chemotherapy+Best Supportive Care (BSC)
C: Arm Label: Arm A (ECF + cetuximab); Type: EXPERIMENTAL; Interventions: Biological: cetuximab, Drug: ECF | Arm Label: Arm B (IC + cetuximab); Type: EXPERIMENTAL; Interventions: Biological: cetuximab, Drug: IC | Arm Label: ARM C (FOLFOX + cetuximab); Type: EXPERIMENTAL; Interventions: Biological: cetuximab, Drug: FOLFOX | Intervention Type: BIOLOGICAL; Name: cetuximab; Assigned to Arm(s): ARM C (FOLFOX + cetuximab), Arm A (ECF + cetuximab), Arm B (IC + cetuximab) | Intervention Type: DRUG; Name: ECF; Assigned to Arm(s): Arm A (ECF + cetuximab) | Intervention Type: DRUG; Name: IC; Assigned to Arm(s): Arm B (IC + cetuximab) | Intervention Type: DRUG; Name: FOLFOX; Assigned to Arm(s): ARM C (FOLFOX + cetuximab)
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: olaparib, Drug: paclitaxel | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: paclitaxel, Drug: Placebo | Intervention Type: DRUG; Name: olaparib; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: paclitaxel; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)
Brief Summary: The purpose of this study is to determine if an integrated intervention addressing active smoking, environmental tobacco smoke exposure, depression and intimate partner violence, would improve pregnancy outcome among African American women.


Options:
A: Arm Label: ROSE Program; Type: EXPERIMENTAL; Interventions: Behavioral: ROSE Program | Arm Label: Control Condition; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ROSE Program; Assigned to Arm(s): ROSE Program
B: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
C: Arm Label: Qigong training; Type: EXPERIMENTAL; Interventions: Behavioral: Qigong training | Arm Label: Wait-list control- Health talks; Type: OTHER; Interventions: Other: Wait-list control- Health talks | Intervention Type: BEHAVIORAL; Name: Qigong training; Assigned to Arm(s): Qigong training | Intervention Type: OTHER; Name: Wait-list control- Health talks; Assigned to Arm(s): Wait-list control- Health talks
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated psychotherapy for PTSD and substance use | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-step based supportive therapy | Intervention Type: BEHAVIORAL; Name: Integrated psychotherapy for PTSD and substance use; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: 12-step based supportive therapy; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)
Brief Summary: The purpose of this study is to determine if an integrated intervention addressing active smoking, environmental tobacco smoke exposure, depression and intimate partner violence, would improve pregnancy outcome among African American women.


Options:
A: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Stepping Stones | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: stepping Stones short | Intervention Type: BEHAVIORAL; Name: Stepping Stones; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: stepping Stones short; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Screening for intimate partner violence | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Screening for intimate partner violence; Assigned to Arm(s): 1
D: Intervention Type: PROCEDURE; Name: Woman Abuse Screening Tool; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Partner Violence Screen; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Computerized screening; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Face to face screening; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Written screening on forms; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)
Brief Summary: The purpose of this study is to determine if an integrated intervention addressing active smoking, environmental tobacco smoke exposure, depression and intimate partner violence, would improve pregnancy outcome among African American women.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Public Health Nurse Home Visit | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intimate Partner Violence (IPV) Protocol | Intervention Type: BEHAVIORAL; Name: Public Health Nurse Home Visit; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Intimate Partner Violence (IPV) Protocol; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Home Visiting; Assigned to Arm(s): N/A
D: Arm Label: Standard IPV Assessment; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment | Arm Label: Standard DOVE intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Standard IPV Assessment, Behavioral: Standard DOVE Intervention | Intervention Type: BEHAVIORAL; Name: Standard IPV Assessment; Assigned to Arm(s): Standard DOVE intervention, Standard IPV Assessment | Intervention Type: BEHAVIORAL; Name: Standard DOVE Intervention; Assigned to Arm(s): Standard DOVE intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)
Brief Summary: The purpose of this study is to determine if an integrated intervention addressing active smoking, environmental tobacco smoke exposure, depression and intimate partner violence, would improve pregnancy outcome among African American women.


Options:
A: Arm Label: Internet Based Safety Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based safety decision aid | Arm Label: Control Website; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care Safety Plan | Intervention Type: BEHAVIORAL; Name: Internet-based safety decision aid; Assigned to Arm(s): Internet Based Safety Decision Aid | Intervention Type: BEHAVIORAL; Name: Usual Care Safety Plan; Assigned to Arm(s): Control Website
B: Intervention Type: BEHAVIORAL; Name: Home Visiting; Assigned to Arm(s): N/A
C: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: The SHARE Project | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The SHARE Project; Assigned to Arm(s): Intervention arm
D: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)
Brief Summary: The purpose of this study is to determine if an integrated intervention addressing active smoking, environmental tobacco smoke exposure, depression and intimate partner violence, would improve pregnancy outcome among African American women.


Options:
A: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
B: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: 2 mg nicotine polacrilex | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): A | Intervention Type: DRUG; Name: 2 mg nicotine polacrilex; Assigned to Arm(s): B
C: Intervention Type: BEHAVIORAL; Name: Nicotine Replacement Therapy; Assigned to Arm(s): N/A
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Computerized brief intervention (5As); Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As) | Arm Label: Contingency Management Alone; Type: EXPERIMENTAL; Interventions: Behavioral: Contingency Management | Arm Label: Combined Brief Intervention and CM; Type: EXPERIMENTAL; Interventions: Behavioral: Computer-delivered brief intervention (5As), Behavioral: Contingency Management | Intervention Type: BEHAVIORAL; Name: Computer-delivered brief intervention (5As); Assigned to Arm(s): Combined Brief Intervention and CM, Computerized brief intervention (5As) | Intervention Type: BEHAVIORAL; Name: Contingency Management; Assigned to Arm(s): Combined Brief Intervention and CM, Contingency Management Alone

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)
Brief Summary: The purpose of this study is to determine if an integrated intervention addressing active smoking, environmental tobacco smoke exposure, depression and intimate partner violence, would improve pregnancy outcome among African American women.


Options:
A: Intervention Type: BEHAVIORAL; Name: Nicotine Replacement Therapy; Assigned to Arm(s): N/A
B: Arm Label: Implementation of intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Training in smoking cessation counseling | Arm Label: No implementation of the intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training in smoking cessation counseling; Assigned to Arm(s): Implementation of intervention
C: Arm Label: High intensity intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Higher intensity intervention | Arm Label: Low intensity intervention; Type: OTHER; Interventions: Behavioral: Low intensity intervention | Intervention Type: BEHAVIORAL; Name: Low intensity intervention; Assigned to Arm(s): Low intensity intervention | Intervention Type: BEHAVIORAL; Name: Higher intensity intervention; Assigned to Arm(s): High intensity intervention
D: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)
Brief Summary: The purpose of this study is to determine if an integrated intervention addressing active smoking, environmental tobacco smoke exposure, depression and intimate partner violence, would improve pregnancy outcome among African American women.


Options:
A: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: The SHARE Project | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The SHARE Project; Assigned to Arm(s): Intervention arm
B: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Prolonged Exposure (PE) Therapy | Intervention Type: BEHAVIORAL; Name: Prolonged Exposure (PE) Therapy; Assigned to Arm(s): 2
D: Arm Label: Brief Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement Therapy | Arm Label: Assessed Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: No Contact Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement Therapy; Assigned to Arm(s): Brief Intervention Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention for Risk Factors in Pregnant Women in Washington, D.C. (DC-HOPE)
Brief Summary: The purpose of this study is to determine if an integrated intervention addressing active smoking, environmental tobacco smoke exposure, depression and intimate partner violence, would improve pregnancy outcome among African American women.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Public Health Nurse Home Visit | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intimate Partner Violence (IPV) Protocol | Intervention Type: BEHAVIORAL; Name: Public Health Nurse Home Visit; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Intimate Partner Violence (IPV) Protocol; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: Home Visiting; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A
D: Arm Label: Primary Care for DILs; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Primary care for Daughters-in-Law | Arm Label: Standard Care plus Dil Mil Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: The Dil Mil Intervention | Intervention Type: BEHAVIORAL; Name: Primary care for Daughters-in-Law; Assigned to Arm(s): Primary Care for DILs | Intervention Type: BEHAVIORAL; Name: The Dil Mil Intervention; Assigned to Arm(s): Standard Care plus Dil Mil Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vitamin D Dose-Response Study to Establish Dietary Requirements in Infants
Brief Summary: The research team is comprised of an expert nutrition scientist and a pediatrician with expertise in endocrinology. Both have world-class experience in assessing bone mass in infancy. Together they have designed a study to determine how much dietary vitamin D is needed to optimize health in infants. This is important since many infants are born with vitamin D deficiency. At present the dosage of vitamin D that is optimal for infant health is unclear and recent research suggests that vitamin D status very early in life has long lasting effects on bone mass and other health issues. Therefore, in a group of healthy infants, this research team will test which dosage of vitamin D is needed to achieve optimal vitamin D status. Optimal vitamin D status will be based on growth, biomarkers of vitamin D and bone status in blood and also general health. The infants will all be breastfed and begin the study at about 2 weeks of age. At 3 months intervals over the first year of life, each infant will be measured for growth, duration of breastfeeding and supplement use plus have a bone density scan to determine changes in bone growth. The data will be helpful to guide health care professionals in providing the best care possible for their infants. It will also be important to the health of populations since dietary recommendations for vitamin D are used to guide fortification of foods and development of evidence based policy around nutrient recommendations and their implementation.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 3
B: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Other: Childhood Obesity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Childhood Obesity; Assigned to Arm(s): Treatment
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: KAN-DO | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: KAN-DO | Intervention Type: BEHAVIORAL; Name: KAN-DO; Assigned to Arm(s): 1, 2
D: Arm Label: Healthy Lifestyles Group; Type: EXPERIMENTAL; Interventions: Behavioral: Keys to Healthy Family Child Care Homes | Arm Label: Healthy Business Group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Keys to Healthy Family Child Care Homes | Intervention Type: BEHAVIORAL; Name: Keys to Healthy Family Child Care Homes; Assigned to Arm(s): Healthy Business Group, Healthy Lifestyles Group

Answer: A